Psychosocial Oncology and Mental Health Support Flashcards

The National Comprehensive Cancer Network (NCCN) recommends using which validated tool as the primary distress screening instrument in oncology settings?

Answer: NCCN Distress Thermometer

The NCCN Distress Thermometer is the NCCN's recommended brief screening tool, consisting of a 0–10 numerical scale and a problem checklist that identifies practical, family, emotional, spiritual, and physical concerns. A score of 4 or higher warrants further evaluation and referral. While PHQ-9, HADS, and GAD-7 are valid tools, the Distress Thermometer is specifically recommended by NCCN guidelines as the primary oncology distress screen.

A patient undergoing active chemotherapy reports persistent low mood, loss of interest in activities, and fatigue for the past 3 weeks. When assessing for major depressive disorder, which symptom is LEAST useful for diagnostic discrimination in cancer patients?

Answer: Persistent fatigue and low energy

Fatigue and low energy are near-universal side effects of chemotherapy and therefore have poor discriminative validity for depression in cancer patients — virtually all patients undergoing active treatment experience these symptoms. Cognitive-affective symptoms such as worthlessness, guilt, anhedonia, and suicidal ideation are more diagnostically specific for depression in this population, as they are less confounded by treatment side effects.

Which intervention has the strongest evidence base for reducing cancer-related fatigue (CRF) in patients who have completed active treatment?

Answer: Aerobic exercise and physical activity

Multiple systematic reviews and RCTs support aerobic exercise as the most effective intervention for cancer-related fatigue in survivors, improving both fatigue severity and quality of life. Corticosteroids are used short-term in palliative contexts. Methylphenidate has modest evidence and is typically reserved for specific populations with severe fatigue. Prolonged rest paradoxically worsens CRF by reducing physical conditioning and disrupting sleep architecture.

An oncology NP is caring for a 52-year-old woman who underwent bilateral mastectomy and is now experiencing significant body image distress and avoidance of sexual intimacy. Which psychosocial approach is most evidence-based for this presentation?

Answer: Referral to a sex therapist using Cognitive-Behavioral Therapy (CBT) adapted for cancer

CBT adapted for cancer-related sexual dysfunction and body image disturbance has the strongest evidence base among psychosocial interventions. It addresses negative automatic thoughts about body image, communication skills, and intimacy. Antidepressants may worsen sexual dysfunction. Minimizing appearance concerns is dismissive and damages therapeutic alliance. Reconstruction may address physical appearance but does not treat the underlying psychosocial distress without adjunct therapy.

During a routine follow-up visit, the family caregiver of a patient with advanced cancer appears exhausted and tearful, stating 'I can't do this anymore.' Which of the following best represents the oncology NP's priority response?

Answer: Conduct a formal caregiver burden assessment and connect the caregiver with psychosocial support resources

Caregiver burden is a recognized domain of oncology NP practice. The priority is to formally assess the caregiver's level of distress (tools include the Zarit Burden Interview or Caregiver Strain Index) and immediately connect them with available support resources — social work, caregiver support groups, respite care options. Deferring assessment is a patient safety concern. Reassurance minimizes a real crisis. Inpatient hospice may not be appropriate or desired and leapfrogs assessment.

According to established oncology psychosocial guidelines, which population of cancer patients has the highest documented prevalence of clinically significant depressive disorders?

Answer: Patients with pancreatic cancer

Pancreatic cancer is consistently associated with the highest prevalence of depression among all cancer types, with rates reaching 33–50% at diagnosis. Proposed mechanisms include direct neurobiological effects of the tumor, paraneoplastic inflammation, early symptom burden, and poor prognosis. This is clinically important because depression in pancreatic cancer can precede diagnosis by months and is often underrecognized. The other groups have notable but lower rates of clinical depression.